Three-year ban on new medical colleges
The committee, which met here with Senator Aamir Waleeduddin in the chair, discussed the PMDC Amendment Bill moved by Senator Humayun Mohmand. The bill proposed to include parliamentarians in the PMDC board. However, Health Minister Mustafa Kamal opposed the proposal.
PMDC President Dr Rizwan Taj said that parliamentarians had never been part of the board, but the chair corrected him, stating that a senator and a MNA used to sit on the board.
Irfan Siddiqui said that the inclusion of political people would not change the institution's structure.
Mustafa Kamal told the committee that even he, as the health minister, was not part of the PMDC board.
He maintained that Pakistan's medical professionals were still respected globally, and political involvement could undermine their reputation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
a day ago
- Business Recorder
TIP urges govt to implement generic medicine policy
ISLAMABAD: Transparency International Pakistan (TIP), while advocating for the promotion of generic based medicines to end consumers, urged the government to implement the generic medicine policy to purchase and prescribe medicines with generic name only to benefit the masses. In a written letter to Federal Minister for National Health Services and Regulations Mustafa Kamal, the TIP has also recommended the government to use of least cost method in public sector procurement of drugs which are registered and approved by the Drug Regulatory Authority of Pakistan (DRAP) to save annually billion of rupees to the exchequer and citizens. TIP refers to its letters dated 22 April 2021 and 9th June 2021 addressed to the managing director, Public Procurement Regulatory Authority (PPRA) and officer of the prime minister. TIP has highlighted the need that drugs/medication be made available to the ordinary citizens at the cheapest price possible. In this regard, the chief executive officer of DRAP issued an advisory to all provinces and federal controlled units, on 16th April 2021, to ensure that doctors prescribe medicines with their generic names instead of brand names, in the public and private sector throughout the country as this practice adds to the economic burden of the country. However, this policy is facing failure of implementation. According to Drug Regulatory Authority of Pakistan Act, 2012 (DRAP Act), and under Article 7, Powers and functions of the Authority, all Medicines/Drugs shall be approved and registered with DRAP, and that DRAP is the only approving authority in Pakistan for quality of medications and once it registers a medicine, for example Aspirin, it means that the Aspirin's quality and MRP is approved by DRAP. The TIP has also drawn a comparison between the cheapest and costliest medicines of same generic, for instance an Aspirin 10 tablet pack manufactured by Karachi Pharmaceutical Laboratory was available at Rs47 while same medicine manufactured by another company Euro Pharma International was available at Rs300 per pack. From above examples it can be seen that on average branded medicines prices are 3,000 percent to 4,000 percent higher than approved non-branded medicines. When generic medicine policy is implemented, public will get 90 percent relief in medical expenses. The best international practices highlight that a generic medicine system is often considered beneficial for a national health policy due to its potential to improve affordability, accessibility, and efficiency in healthcare. This is because: Generic medicines are significantly cheaper and cost-effective than the brand-name drugs. Generic medicines increase access as lower costs mean more people, especially in low- income or underserved populations, can afford essential medications. In Pakistan, where affordable healthcare is a problem for wider section of the society, generic medicines can promote equitable healthcare access and help address disparities in treatment across socioeconomic groups. Generic medicines can also foster competition in the pharmaceutical market in Pakistan, which can drive down prices further and incentivise innovation in cost-effective drug production. TIP requests the Federal Minister for Health to look into TI Pakistan's recommendations, probe into non-implementation of generic medicine guidelines despite clear directives of the past and issues directives on implementing generic medicine policy to save billions to the national exchequer and the citizens of Pakistan. The TIP is striving for across the board application of Rule of Law, which is the only way to stop corruption, and achieve against Zero tolerance against Corruption. Copyright Business Recorder, 2025
Business Recorder
5 days ago
- Business Recorder
Pakistan, WHO vow to work hard to fight hepatitis C
ISLAMABAD: Pakistan and World Health Organization (WHO), on Friday, vowing to take all possible steps to effectively deal with hepatitis C have committed to avert 850,000 deaths and one million new infections 2050 under the umbrella of the Prime Minister's National Programme for the Elimination of Hepatitis C. During a review meeting held here under the chairmanship of Federal Minister for National Health Services and Regulation Mustafa Kamal also attended by experts from the Health Ministry and the WHO. According to an estimate, the meeting was informed that, in addition to saving lives, the country will save an estimated Rs3.3 billion over five years by taking hepatitis C prevention measures. Speaking on the occasion, Mustafa Kamal said that this was not just an occasion but a commitment and a mission. He said, 'When it comes to the healthcare system of Pakistan, we have to do everything that we should have done yesterday, but it is never too late. We have to start as soon as possible'. Millions of people are already affected, and many more are getting affected every single day, the government along with other partners must act now to save the people, he maintained. 'The fight against hepatitis is not a job, but a passion, a commitment and a mission. We have to screen our population. The success story is there. The prime minister himself has spoken to the president of Egypt. I call upon all stakeholders to join hands in this mission to protect the health and future of the nation,' said the federal minister. As part of World Hepatitis Day commemorations, WHO and the Ministry of Health convened national and international experts for a discussion, highlighting that, in addition to saving lives, every dollar invested in hepatitis prevention yields an economic return of $11. According to data presented during the event, the implementation of the Prime Minister Programme could save 150,000 lives and avoid 210,000 infections by 2030, preventing 90,000 liver cancer cases and 71,000 cirrhosis cases. This prevention will also save over the next five years Rs1.3 billion or $4.6 million in treatment and over Rs2 billion or $7 million in hospitalisation costs, total savings of Rs3.3 billion. 'As we speak, every 30 seconds someone dies from hepatitis-related severe liver disease or liver cancer. This means that at least eight people will have died due to hepatitis before I finish this speech. I am convinced that, together, under the Government of Pakistan's leadership, we can break hepatitis down,' said WHO Representative in Pakistan Dr DapengLuo. 'Detecting and treating hepatitis is essential, but prevention is the key to end the disease. We will continue to partner with Pakistan to implement science-based approaches and adapt to the Pakistani context best practices and lessons learned from around the world'. With 10 million of the 50 million estimated cases worldwide, Pakistan has the heaviest burden of hepatitis C globally. It is estimated that, every year, 110,000 people are infected in the country – 62 per cent due to unsafe medical injections (including blood transfusions) and 38 per cent due to injection drug use. Under the theme 'Let's break it down', the WHO is urging policymakers and health authorities worldwide to simplify, scale up and integrate hepatitis services into national health systems – including vaccination, safe injection practices, harm reduction, and especially testing and treatment. The goal: ending hepatitis as a public health problem by 2030. The WHO reiterates its full support for Pakistan's efforts to fight the disease, including the Prime Minister's National Programme for the Elimination of Hepatitis C Infection. The programme aims to test 50 per cent of the eligible population (82.5 million people aged 12 years and above) and treat five million people by 2027. Copyright Business Recorder, 2025
Express Tribune
26-07-2025
- Express Tribune
18 illegal aesthetic centres sealed
Assistant Director of SHCC Ahmer Abbas Saldera stands beside a pile of discarded, empty beauty drips at an illegal aesthetic clinic in DHA Phase II. PHOTO: EXPRESS The Sindh Healthcare Commission (SHCC) has stepped up its crackdown on unregistered and illegal aesthetic clinics operating in the metropolis, sealing at least 18 facilities over the past month in different neighbourhoods, including Clifton, DHA, Saddar, Ittehad Town, and Ranchore Line. In most cases, the clinics were operating without qualified medical professionals, with procedures being administered by untrained staff, including a sociology graduate running a clinic in DHA. SHCC officials reported widespread violations such as unhygienic conditions, improper disposal of medical waste, and the use of unverified techniques, including skin-whitening drips and anti-aging treatments. "We have inspected more than 80 suspect clinics so far, and the crackdown will continue until such illegal practices are rooted out," Ahmer Abbas Saldera, Assistant Director of SHCC's Anti-Quackery Wing, told The Express Tribune. In a recent raid, SHCC sealed a clinic in DHA Phase II despite efforts by the owner to intervene via phone calls. Video footage of the raid, along with disturbing visuals of unsanitary conditions at other clinics, has been shared with the media, revealing the grave risks posed by these clinics. SHCC Chief Executive Officer Dr Ahson Qavi Siddiqi urged the public to avoid unverified aesthetic centres and stressed that all procedures, including skin therapies, injectables, facials, and beauty drips, must be administered only under the supervision of Pakistan Medical and Dental Council (PMDC)-certified dermatologists. "There is currently no PMDC-recognised qualification in aesthetics in Pakistan. Many so-called 'aesthetic experts' are either physiotherapy graduates or those without any formal medical background. Their operations, often marketed on social media and morning TV shows, are misleading and medically unsound," he said. Dr Siddiqi added that some clinics prominently display large promotional billboards featuring fake designations and celebrity endorsements. He warned that such practices not only violate the law but also endanger the lives and well-being of unsuspecting clients. The SHCC is now in the process of drafting technical guidelines to regulate the aesthetics sector, with an aim to allow only certified, evidence-based practices. CEO Siddiqi also expressed concern over the role of mainstream media, particularly morning shows, where unqualified people are frequently introduced as "doctors" dispensing beauty advice and medical tips without proper credentials. He pointed out that, due to a legal grey area, SHCC is currently unable to inspect salons offering aesthetic services unless a formal complaint is received. He called for comprehensive legislation to bring such services under regulatory oversight. Among the procedures being offered at these clinics are PRP (Platelet Rich Plasma) therapy, Botox and dermal fillers, LED light therapy, micro-needling, chemical peels, and laser treatments - all of which require trained medical oversight. Without proper regulation, these services can lead to serious health complications.
